Atrial fibrillation (AF) increases stroke risk five-fold. This video explains how this risk could be reduced through appropriate anticoagulation.

It features Arrhythmia Alliance and AF Association CEO, Trudie Lobban MBE, AF Association Deputy CEO, Jo Jerrome, leading heart rhythm specialist, Professor John Camm and CEO of Anticoagulation Europe, Eve Knight.

Developed in association with Boehringer Ingelheim.

свернуть